Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 60 2009 051 441.5 |
96 | EP file number | EAKZ | 15 15 1165.6 |
97 | EP publication number | EPN | 2889033 |
54 | Designation/title | TI | Behandlung von negativen Symptomen der Schizophrenie mit (R)-7-Chlor-N-(quinuclidin-3-yl)benzo[b]thiophen-2-carboxamid und pharmazeutisch verträgliche Salze davon |
51 | IPC main class | ICM (ICMV) | A61K 31/439 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61P 25/00 (2006.01) |
22 | DE application date | DAT | Nov 19, 2009 |
96 | EP application date | EAT | Nov 19, 2009 |
43 | Date of first publication | OT | Jul 1, 2015 |
| Date of publication of grant | PET | Mar 21, 2018 |
71/73 | Applicant/owner | INH | Forum Pharmaceuticals Inc., Waltham, Mass., US |
72 | Inventor | IN | Koenig, Gerhard, Newton, MA Massachusetts 02465, US; Chesworth, Richard, Boston, MA Massachusetts 02111, US; Shapiro, Gideon, Gainsville, FL Florida 32653, US |
| Address for service | | RWS Group, Translation Division, CHALFONT ST PETER, Bucks SL9 9FG, GB |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 116106 P Nov 19, 2008
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002889033 Searchable text:
EP000002889033 Original document:
EP000002889033B1 Searchable text:
EP000002889033B1 |
43 | Date of first publication | EVT | Jul 1, 2015 |
| Date of the first transfer into DPMAregister | EREGT | Jul 2, 2015 |
| Date of the (most recent) update in DPMAregister | REGT | Aug 26, 2021 (Show all update days)(Hide all update days)Jul 2, 2015; Aug 14, 2015; Sep 7, 2017; Mar 8, 2018; Mar 13, 2018; Apr 19, 2018; Oct 18, 2018; Feb 7, 2019; Mar 14, 2019; Mar 28, 2019; Aug 21, 2019; Oct 24, 2019; Jul 17, 2021; Aug 26, 2021 |